
Immuneering Corp (IMRX) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.97
Average-0.9180
Median-0.9300
Minimum-1.10
Maximum-0.7300
-0.97
Past Month-0.32 (49.23%)
The P/E ratio for Immuneering Corp (IMRX) is -0.97 as of Jun 13, 2025. This represents a increase of 12.79% compared to its 12-month average P/E ratio of -0.86. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Immuneering Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Immuneering Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Immuneering Corp to industry peers.
Immuneering Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Immuneering Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Immuneering Corp to industry peers.
Immuneering Corp (IMRX) P/E Ratio Insights
See Immuneering Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Immuneering Corp (IMRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Immuneering Corp (IMRX) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.87 | -0.95 |
May 1, 2025 | $1.29 | -0.63 |
Apr 1, 2025 | $1.50 | -0.74 |
Mar 3, 2025 | $1.48 | -0.75 |
Feb 3, 2025 | $1.88 | -0.96 |
Jan 2, 2025 | $2.21 | -1.12 |
Immuneering Corp (IMRX) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.97 | -13.39% |
2024 | -1.12 | -71.50% |
2023 | -3.93 | +47.74% |
2022 | -2.66 | -78.77% |
2021 | -12.53 | — |
FAQs About Immuneering Corp (IMRX) P/E ratio
The latest P/E ratio of Immuneering Corp (IMRX) is -0.97, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Immuneering Corp’s last 12-month average P/E ratio is -0.86, compared to its current P/E ratio of -0.97. This reflects a increase of 12.79%.
Immuneering Corp’s current P/E ratio of -0.97 is higher than its last 12-month average P/E of -0.86. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Immuneering Corp’s average P/E ratio over the last 3 years is -2.86. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Immuneering Corp’s average P/E ratio over the last 5 years is -2.55. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.